In DIAlysis patient study of efficacy and safety of MONthly minoDoronate
Not Applicable
- Conditions
- osteoporosis in dialysis patients
- Registration Number
- JPRN-UMIN000010185
- Lead Sponsor
- Oita university facility of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients who have obstacles which delays esophagus passage of stricture of the esophagus or achalasia 2)Patients who have raised the upper part of the body for 30 minutes or it cannot be standing 3)hypersensitivity for bisphosphonate 4)The patient with hypocalcemia 5)Patients in or expecting pregnancy 6)Patients who diagnosed malignancy 7)Patients receiving specific treatments that affect bone and mineral metabolism such as recombinant human PTH, and Eldecalcitol 8)Patients who took SERM within a month before this trial 9)Patients who took bisphophonate within 6 month before this trial 10)Patients who are inappropriate for this study by physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method